BridgeMD
New treatment option for Alcohol Use Disorder
Official title Integrated Treatment for Enhancing Growth in Recovery During Adolescence
ClinicalTrials.gov ID: NCT06395467
What this study is testing
- What it's testing
- This is a Phase II parallel group randomized controlled trial with 294 adolescents (age: 14-21 years) with alcohol and other drug [AOD] use disorder (hereafter substance use disorder), that compares two different active psychosocial interventions designed to address adolescent substance use disorder. Participants are recruited from our clinical settings and the community at two sites: one in the metro Boston, Massachusetts (MA) area and the other in the metro Farmington, Connecticut (CT), area.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 21
You may be able to join if
- 14-21 years old
- SUD based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)
- able to read and comprehend English at a 5th-grade level
- residence in Eastern time zone states (Connecticut, Delaware, Florida, Georgia, Indiana, Kentucky, Maine, Maryland, Massachusetts, Michigan, New...
- any AOD use in the past 90 days (or in the 90 days prior to being in a controlled environment)
You likely can't join if
- suicidal ideation with a plan, suicidal behavior, a plan to hurt oneself or others, or a history of self-injurious behavior occurring in past 30 days
- lifetime diagnosis of schizophrenia
- current health condition (i.e., medical, psychiatric) that compromises participant's ability to attend outpatient treatment
- demonstrate inability or unwillingness to identify a "locator" who could be contacted in case participant becomes lost to follow-up; or
- youth attending another SUD treatment program or receiving psychotherapy that could conflict with study treatments.
See the full eligibility criteria
- 14-21 years old
- SUD based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)
- able to read and comprehend English at a 5th-grade level
- residence in Eastern time zone states (Connecticut, Delaware, Florida, Georgia, Indiana, Kentucky, Maine, Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode...
- any AOD use in the past 90 days (or in the 90 days prior to being in a controlled environment)
- meet patient placement criteria for level I (outpatient) treatment
- participant and a family member/guardian responsible for providing collateral information (for those \<18 years) agree to sign Institutional Review Board (IRB)-approved consent
- participant and family member responsible for providing collateral information who could be contacted in case the subject became lost to follow-up.
- suicidal ideation with a plan, suicidal behavior, a plan to hurt oneself or others, or a history of self-injurious behavior occurring in past 30 days
- lifetime diagnosis of schizophrenia
- current health condition (i.e., medical, psychiatric) that compromises participant's ability to attend outpatient treatment
- demonstrate inability or unwillingness to identify a "locator" who could be contacted in case participant becomes lost to follow-up; or
- youth attending another SUD treatment program or receiving psychotherapy that could conflict with study treatments.
The study team makes the final eligibility decision.
Where it's taking place
- Farmington, Connecticut, United States
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Farmington, Connecticut, United States; Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.